Global Blood Therapeutics (GBT) Reports Q4 Loss of $0.74/Share
Tweet
Share
E-mail
Get Alerts GBT Hot Sheet
Price: $68.49 --0%
Financial Fact:
Research and development expenses: 298.26K
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Research and development expenses: 298.26K
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q4 EPS of ($0.74), versus ($0.53) reported last year.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
- ULTA Beauty (ULTA) PT Lowered to $710 at UBS Amid Gross Margin Decline
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
